Your session is about to expire
← Back to Search
Telemedicine Assessment for Autism (TAP-P Trial)
N/A
Recruiting
Led By Zachary Warren, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Novel sample (n = 120): English/Spanish Speaking families with children 36-72 months of age, access to a device capable of supporting Zoom, and has not participated in a diagnostic evaluation
Be younger than 18 years old
Must not have
Initial deployment (n = 30): Severe sensorimotor impairments
Novel sample (n = 120): Severe sensorimotor impairments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights
No Placebo-Only Group
Summary
This trialis developing a telemedicine tool to improve access to ASD diagnosis for underserved groups, such as those with long waitlists or long distances to care.
Who is the study for?
This trial is for preschool children aged 36-72 months who may have autism. It's open to English or Spanish-speaking families with access to a device that supports Zoom. The study includes kids both previously evaluated for autism and those not yet assessed.
What is being tested?
The trial is testing the TAP-Preschool, a new telemedicine tool designed to assess the risk of autism in preschoolers remotely. It compares results from this tool with traditional in-person assessments to see if it can improve care access.
What are the potential side effects?
Since this trial involves assessment tools rather than medication, there are no direct physical side effects expected. However, participating families might experience stress or anxiety related to the use of technology and concerns about their child's development.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I speak English or Spanish, have a child aged 3-6, can use Zoom, and haven't had a diagnostic evaluation.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe difficulties in feeling or moving parts of my body.
Select...
I have severe difficulties with movement and sensation.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Diagnostic Certainty: In-person assessment
Diagnostic Certainty: Tele-assessment
Family Satisfaction
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Tele-assessment + In-person assessmentExperimental Treatment1 Intervention
All families will receive an in-person tele-assessment appointment and an in-person evaluation.
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
905 Previous Clinical Trials
933,949 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,283 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,931 Previous Clinical Trials
2,744,892 Total Patients Enrolled
84 Trials studying Autism Spectrum Disorder
41,102 Patients Enrolled for Autism Spectrum Disorder
Zachary Warren, PhDPrincipal InvestigatorVanderbilt University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have severe difficulties in feeling or moving parts of my body.I have severe difficulties with movement and sensation.My family speaks English or Spanish, has a child aged 3-6, can use Zoom, and we've had a diagnostic evaluation.I speak English or Spanish, have a child aged 3-6, can use Zoom, and haven't had a diagnostic evaluation.
Research Study Groups:
This trial has the following groups:- Group 1: Tele-assessment + In-person assessment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.